Actis
Device Ortho-Hip
PDI 10603295380801
General payments
$30,734,120
Research payments
$136,648
Through program year 2025, $30,734,120 in general payments and $136,648 in research payments were reported against Actis (Ortho-Hip).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
10 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $5,693,871 | 2,386 |
| 2025 | Research | $22,722 | 3 |
| 2024 | General | $7,296,150 | 1,320 |
| 2024 | Research | $11,067 | 3 |
| 2023 | General | $6,751,868 | 2,059 |
| 2023 | Research | $7,625 | 5 |
| 2022 | General | $5,740,298 | 560 |
| 2022 | Research | $47,610 | 18 |
| 2021 | General | $5,251,934 | 881 |
| 2021 | Research | $47,623 | 15 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 40 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 47 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
7,206 general · 44 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.